Lots of questions rolling in about this one — it’s a pitch for Sean Brodrick’s Oxford Resource Explorer, which these days is offered at $79 a year (or $49 for email-only)… though the letter is actually signed by David Fessler, one of their analysts who has generally been touted as an energy and resource expert […]
Articles
- Most Relevant
- Most Recent
Late last week I started digging into a teaser from Sean Brodrick at Oxford Resource Explorer that promised “three supercharger plays” for the bull market in precious metals that he expects — and though I only “solved” the first teased stock that day I promised to follow up and catch up on the other two. […]
Exponential Tech Investor is a relatively new newsletter service from the Bonner & Partners stable, but that Bonner/Agora connection means it’s getting a lot of play — and we’ve seen a lot of questions about this latest pitch for the service that hints at a “Tiny Device” that editor Jeff Brown says is “Changing the […]
Brett Eversole has a new ad letter out promoting subscriptions to True Wealth, Steve Sjuggerud’s “entry level” newsletter service over at Stansberry, and it sounds awfully exciting — how do we make 500% returns, and what’s the “tiny device that’s eating the world?” Well, the ad is all about mobile payments — using your cell […]
Frank Curzio has graced the pages of Gumshoe quite a few times over the years, under the aegis of several different publishers, but this is the first time he has actively promoted his new self-published “front end” newsletter, Curzio Research Advisory (he launched his “back end” newsletter, Curzio Venture Opportunities, late last year). I don’t […]
This is shaping up to be “bitcoin week” here at Stock Gumshoe — I wrote a bit more about my (befuddled and pessimistic) opinion about bitcoin itself late last week, and we got things rolling on Monday with David Gardner’s “bitcoin backdoor” stock… … and today, we move on to Jeff Brown at Bonner and […]
Biotech trading advisory/newsletter, designed to make shorter-term trades around “catalyst” events, mostly in drug development (previously called FDA Trader when the publisher was still called Agora Financial, Blanco took over after previous editor Paul Mampilly left).
Focuses on timing and disruptive trends, and technology and innovation companies with a market value of $3-5 billion or higher entering the first wave of growth.
Dear Friends Let’s keep the group “Paul Mampilly’s 100x deal” going Thank you
That’s right, the end of obesity. That’s what’s being touted by the new letter that as far as I can tell was just launched moments ago by Agora, which they’re calling FDA Trader and for which they apparently hired away Paul Mampilly from the Palm Beach Letter (OK, they didn’t really “hire him away” — […]
Crazy earnings week, eh? That leads me to a few adjustments to the portfolio, as my opinions have changed about a few stocks at the top of the Real Money Portfolio. So this week your Friday File is another run through a hodgepodge of stocks, starting with the one that I think is looking most […]
This is an update of an article that was first published on March 8, 2023, when the ad we’re talking about first appeared (the ad has not been udpated, but seems to still be in heavy rotation). Ian King’s Extreme Fortunes ($2,995/yr, no refunds) is being marketed now with a presentation about the “Fourth Convergence” […]
We’ve been getting teaser pitches for a “forever battery” for years now, ever since the earliest solid state battery companies began to come public (and even before, actually). One of the most frequently trumpeted ads for a “forever battery” came from Paul Mampilly at Banyan Hill in a very misleading pitch that primarily focused on […]
It looks like we’ve got another marketing wave from Bonner & Partners coming, this time in service of Jeff Brown’s Near Future Report ($199/yr), and we’re teased about the massive riches available from the advancements in artificial intelligence. And the promises are, of course, huge… here’s a bit of the spiel: “Remember when Apple made […]
I know I’ve said this before, and sometimes it’s a lie: I’m going to try to keep this one brief. Agora Financial’s FDA Trader service has a new pitch out — which normally might not get that much attention, since everyone is suddenly terrified of biotech stocks after a brutal month or two — but […]
I always like reading Chris Mayer’s stuff — he often presents at the Value Investing Congress, he seems to be an interesting and low-key guy in person, and the ideas that are pitched by his various newsletters at Agora often catch my eye. They don’t always work out, of course, but every once in a […]
The focus is to help equity investors and traders to understand and learn trend following and money management.
Has anyone seen this pitch and figured out what it is? ”For instance, one publicly traded animal-health company at the forefront of the pet economy has seen its stock rise 21% this year alone — beating the industry’s overall 10% growth rate 2-to-1, and the broad market in general. Revenue and net income for the […]
e looked in some detail at the two “Landlord Nation” stocks pitched by Monthly Money Flows yesterday, and today we dig into three other ideas that are hinted at in that ad as investments which will benefit from the rise of the landlords. If you missed the first bit, you can click here for that […]
September 30, 2018 / backoffice
What’s Paul Mampilly’s pick for robotics he touting in his Prosperity Kit?
He’s claiming through his ad that this stock needs to be bought now , He’s running a special for this at $495.00. Thanks Travis
the industry and allow a movie to be downloaded in about 2 minutes and is claiming it will be an I-phone killer. Thanks Travis
I feel like I’m waggling back and forth on a strange tightrope, as I’ve been doing for about a year and a half now, and I sum it up kinda like this: I’m quite nervous about the valuations of the overall market and about the massive debt load for both governments and individuals in the […]
Does anyone know what Paul’s pick is for revolutionizing the world of cancer treatment using advanced robotic surgery technology?
But what if you could buy one tiny stock today for $10 that is at the center of a growing tech industry experts believe will explode a massive 77,400%? Wall Street legend Paul Mampilly recently identified this Stock of the Century. It is issued by a little-known company he predicts will become the main “chipmaker” […]
Did anyone watch his presentation and get the Cryptocurrency he is recommending to buy? Appreciate the information if possible.
Did anybody else suffer through the hour long video from Adam Sharp on his 2500.00 Crypto Currency service? Anybody care to weigh in on His service or Cryptos on the whole? Travis I know you held some for awhile. Any opinion? I don’t really know enough about it to form an opinion except He reminds […]
And right now, I’ve uncovered an “off-the-radar” company that is set to dominate one the fastest growing markets in the world. A market exploding from $12 billion in 2012 to an estimated $106 billion in 2021. That’s a surge of 736%. Massive growth that has big players like Google, Microsoft and Apple salivating at the […]
Lots of folks have been asking about Dave Forest’s ad for Brandt Oil, which is apparently in every email inbox in the land this week… the ad is for Casey’s International Speculator, which is apparently helmed by Forest now, and for which they’d like to receive $1,995 from you for a year’s subscription (no refunds, […]
Around $10 at the time of pitch, located in California, CEO has PHD from MIT, and AMD has deals with all the companies he mentions. If AMD, one would have already almost doubled their investment! https://pro.banyanhill.com/p/BLOCKVIDEO/PPRLU812/?h=true
Crazy earnings week, eh? That leads me to a few adjustments to the portfolio, as my opinions have changed about a few stocks at the top of the Real Money Portfolio. So this week your Friday File is another run through a hodgepodge of stocks, starting with the one that I think is looking most […]
What is this guy promoting now? Missing Wall Street ”Poster Boy” Releases Shocking Video July 27, 2018September 26, 2017 J.L. Yastine
He sees this growing into a 4 trillion dollar industry that will revolutionize business and has already seen some of the biggest names in business and 90% of government agencies getting on board. Any info on this Travis?
with a return of over 200,000 a year. It sounds like he’s giving recommendation a month. I’m still waiting for STM to takeoff.
average once every 23 days claiming to take 5,000 and turn it into 200,000 within a year. He speaks of 1 trade that returned 321,000 on a 5,000 investment in under 20 days. What is it?
This counts as a “holy crap!” week when it comes to earnings, not because of any huge reporting that moved the market but because of the surge by just one stock, our fad retailer Five Below (FIVE) after earnings on Wednesday night. FIVE is generally lumped into the “dollar store” category, it’s the teen-focused retailer […]
No, these bits won’t be about Melania’s kidney ailment nor yet about what Meghan wore for The Wedding. I wish them both luck – they’ll need it!. However, there continue to be developments on the medical and health-care fronts that may matter to us a good deal more than the doings of those ladies. […]
Have a question in mind that you think is so dumb you’re embarrassed to ask it? That’s what we’re here for today! This bonus post was inspired by a reader who wanted to know “where to ask a dumb question” here on Stock Gumshoe… and while his question was not actually stupid, and I’m happy […]
This is a quickie, dear friends, because, well, it’s a teaser pitch we’ve covered before. But I thought it worthwhile to take another quick look — and not just because I actually own the stock (though I’m sure I do pay more attention to stocks I own than to others). See, this one’s an opportunity […]
The beginning of the latest ad from Marc Lichtenfeld’s Lightning Trend Trader is good and juicy, at the very least… how could you not open up the ad and pay attention? “The KILLER Hiding in Your Medicine Cabinet “These Common Drugs Take a Life Every 12 Minutes (Who’s at Risk?) “Here’s the NEW Breakthrough and […]